YishengBio
IPOYishengBio was founded in 2002, is headquartered in Gaithersburg, United States, lists 501–1000 employees, and has 1 recorded funding round.
- Headquarters
- Gaithersburg, Maryland
- Employees
- 501–1000
- Founded
- 2002
- Business Model
- B2B
- Website
- yishengbio.com
- Last Round
- Series BMar 2021
- Rounds
- 1
- Type
- Public
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
YishengBio (also known as YS Biopharma) develops vaccines and therapeutic biologics for infectious disease and oncology, with R&D and manufacturing operations spanning China and the United States. Its lead program, a next-generation rabies vaccine, has advanced through Phase 2/3 clinical trials in multiple international markets including the Philippines and UAE. The company went public via a 2022 merger with NASDAQ-listed Summit Healthcare Acquisition Corp, later trading as YS Biopharma (NASDAQ: YS) before further corporate restructuring.
Summary
YishengBio is a Biotech company based in Gaithersburg, United States, founded in 2002. It lists 501–1000 employees. Its most recent funding was a Series B round in Mar 2021. Investors include OrbiMed, Oceanpine Capital and F-Prime Capital.
Funding & Exit History
Mar 2023
Sign up to see all 2 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/yishengbio"><img src="https://indexed.vc/api/badge/company/yishengbio" alt="YishengBio on Indexed.vc" width="260" height="76" /></a>